| Authors: |
Nicoli ER; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Al Eisa N; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Cluzeau CV; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Wassif CA; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Gray J; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Burkert KR; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Smith DA; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Morris L; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Cologna SM; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Peer CJ; Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America., Sissung TM; Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America., Uscatu CD; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Department of Cellular and Molecular Biology, University of Medicine and Pharmacy of Craiova, Craiova, Romania., Figg WD; Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America., Pavan WJ; Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Vite CH; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Porter FD; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Platt FM; Department of Pharmacology, University of Oxford, Oxford, United Kingdom. |
